Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2022-03-16 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1911 characters) and contains the header 'RNS Number : 0365F'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, IR, or 10-K. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or CAP), the most appropriate classification is the general Regulatory Filings fallback category.
2022-03-16 English
Further re Directorate Change
Board/Management Information Classification · 1% confidence The document is an official announcement identified by the 'RNS Number' and the reference to RNS, the news service of the London Stock Exchange. The content explicitly discusses the departure of the Chief Financial Officer and stepping down from the Board ('Further re Directorate Change'). This directly corresponds to the definition of Board/Management Information.
2022-03-02 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is a formal notification issued via RNS (RNS Number: 6136C) on February 23, 2022. The content explicitly details a 'Director/PDMR Notification' concerning the 'Disposal of ordinary shares' by Matthew Fowler, the outgoing Chief Financial Officer. This type of transaction report, detailing personal share dealings by directors or persons discharging managerial responsibilities (PDMRs), directly corresponds to the definition of Director's Dealing. Therefore, the appropriate code is DIRS.
2022-02-23 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 5570C'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the Financial Conduct Authority (FCA) as a Primary Information Provider. This structure—a brief, time-sensitive announcement disseminated via the RNS system—fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-02-23 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' related to trading on the London Stock Exchange, which is a standard regulatory announcement. Since this is a general regulatory announcement that doesn't fit into the more specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Earnings Release (ER), it falls under the general regulatory filing category.
2022-02-23 English
Update on Point of Care Covid Test
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated February 23, 2022. It provides an 'Update on Point of Care Covid Test' from 'genedrive plc'. The text details product progress, distribution agreements, and market strategy. Crucially, the document concludes with standard boilerplate text identifying the source as 'RNS, the news service of the London Stock Exchange' and stating that 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure is characteristic of a general regulatory news service announcement, which falls under the 'Regulatory Filings' category (RNS) when it doesn't fit a more specific operational or financial report type (like 10-K, ER, or DIV). Since this is an operational update disseminated via the RNS system, RNS is the most appropriate classification.
2022-02-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.